Satellos Bioscience Inc. (MSCLF)
OTCMKTS · Delayed Price · Currency is USD
0.4644
+0.0048 (1.04%)
Sep 3, 2025, 1:48 PM EDT

Satellos Bioscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
849637726-
Upgrade
Market Cap Growth
108.14%160.46%440.53%-73.94%--
Upgrade
Enterprise Value
47793421-
Upgrade
Last Close Price
0.460.590.330.170.81-
Upgrade
PB Ratio
2.202.031.192.733.15-
Upgrade
P/TBV Ratio
2.202.031.32-9.86-
Upgrade
Debt / Equity Ratio
------5.95
Upgrade
Quick Ratio
13.8613.6711.080.772.575.12
Upgrade
Current Ratio
14.8414.1611.130.792.595.13
Upgrade
Return on Equity (ROE)
-76.43%-51.78%-72.15%-163.48%-301.13%-1404.79%
Upgrade
Return on Assets (ROA)
-42.48%-29.63%-38.28%-56.08%-43.45%-91.37%
Upgrade
Return on Capital (ROIC)
-46.55%-32.03%-43.89%-76.06%-52.31%-152.70%
Upgrade
Earnings Yield
-27.01%-20.42%-32.76%-123.13%-46.99%-
Upgrade
FCF Yield
-24.56%-18.15%-23.92%-61.40%-15.28%-
Upgrade
Buyback Yield / Dilution
-26.47%-32.84%-142.17%-48.20%-35.60%-62.72%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.